Los Angeles Capital Management
WGS icon

Los Angeles Capital Management’s GeneDx Holdings WGS Stock Holding History

Los Angeles Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.52K Sell
95
-10,008
-99% -$569K ﹤0.01% 2068
2026
Q1 		$649K Buy
10,103
+4,086
+68% +$373K ﹤0.01% 789
2025
Q4 		$791K Buy
6,017
+2,583
+75% +$355K ﹤0.01% 724
2025
Q3 		$370K Buy
+3,434
New +$374K ﹤0.01% 1044

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Los Angeles Capital Management's WGS Position: Q2 2026 in Review

Los Angeles Capital Management reduced its GeneDx Holdings (WGS) stake by 99% in Q2 2026, selling an estimated $569K and leaving 95 shares worth $6.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Los Angeles Capital Management first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. The position peaked at $791K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Los Angeles Capital Management held 95 shares of GeneDx Holdings worth $6.52K as of Q2 2026.
  • Los Angeles Capital Management sold 10,008 GeneDx Holdings shares in Q2 2026, an estimated $569K.
  • GeneDx Holdings made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2068 holding.
  • Los Angeles Capital Management first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
  • Los Angeles Capital Management's GeneDx Holdings position peaked at $791K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.